Report forecast the global cardiac
resynchronization therapy devices market to grow at a CAGR of 8.40% over the
period 2014-2019.
According to the WHO, cardiovascular disease is one
of the leading cause of death worldwide. It is estimated that around 17.5
million people died from cardiovascular disease, which accounted for 31% of all
global deaths in 2012. Cardiovascular disease can be prevented by addressing
behavioral risks such as obesity, cigarette smoking, and an unhealthy diet.
CRT device is an implantable medical device that
are used to resynchronize the contractions of the heart’s ventricles by sending
tiny electrical impulses to the heart muscle, to pump the blood more
efficiently.
The report includes the present scenario and the
growth prospects of the global cardiac resynchronization therapy devices market
for the period 2015-2019. The market can be segmented into two product: CRT-D
devices and CRT-P devices.
According to the report, according to WHO,
cardiovascular diseases are the leading cause of death worldwide and accounted
for 31% of all deaths in 2012. Stroke is also expected to be the second-leading
cause of death in Europe by 2030, and it will be the primary cause of the
increase in disability-adjusted years of life lost during the same period.
Stroke and other cardiovascular diseases are expected to rise as the world's
population ages. In addition, the increase in tobacco consumption and obesity
are the major factors contributing to the rise in cardiovascular diseases.
According to WHO, the prevalence of tobacco use is high in Europe. Therefore, a
rise in the incidence of cardiovascular disease in Europe is expected to drive
the market during the forecast period.
Further, the report states that as the increased
acceptance of pacemakers and ICDs will hamper the growth of the market.
Global Cardiac Resynchronization Therapy Devices
Market 2015-2019, has been prepared based on in-depth market analysis with
inputs from industry experts. The report covers the Americas, APAC, and EMEA;
it also covers the market landscape and its growth prospects in the coming
years. The report includes a discussion of the key vendors.
key players in the Global Cardiac Resynchronization
Therapy (CRT) Devices Market: Boston Scientific, Medtronic and St. Jude Medical
Other Prominent Vendors in the market are:
Biotronik, Cook Medical, Sorin Group and Spectranetics
Key Regions
- Americas
- APAC
- EMEA
Key Market Driver
- Rise in Incidence of Cardiovascular Diseases
- For a full, detailed list, view our report
Key Market Challenge
- High Acceptance of Pacemakers and ICDs
- For a full, detailed list, view our report
Key Market Trend
- Focusing on R&D
- For a full, detailed list, view our report
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Spanning over 77 pages and 43 Exhibits
“Global
Cardiac Resynchronization Therapy (CRT) Devices Market 2015-2019” report covers Executive
Summary, List of Abbreviations, Scope of the Report, Market Research
Methodology, Introduction, Market Landscape, Market Segmentation by Product,
Geographical Segmentation, CRT Devices Market in Americas, CRT Devices Market
in EMEA, CRT Devices Market in APAC, Buying Criteria, Market Growth Drivers,
Drivers and Their Impact, Market Challenges, Impact of Drivers and Challenges,
Market Trends, Trends and Their Impact, Vendor Landscape, Key Vendor Analysis.
For
further information on this report, please visit-
http://mrr.cm/4Vb
Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices
